Bhushan D Hardas

US Patent:

20130150449, Jun 13, 2013

Filed:

Feb 6, 2013

Appl. No.:

13/760434

Inventors:

MERZ PHARMA GmbH & CO., KGaA - FRANKFURT am MAIN, DE
Alexander Gebauer - Wiesbaden, DE
Bhushan Hardas - Summerfield NC, US
Bernhard Hauptmeier - Gelnhausen, DE
Rainer Pooth - Bad Soden/Taunus, DE

Assignee:

MERZ PHARMA GmbH & CO. KGaA - FRANKFURT am MAIN

International Classification:

A61K 31/13

US Classification:

514579

Abstract:

The present invention relates to the treatment of an individual afflicted with inflammatory skin diseases comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative.

US Patent:

8394857, Mar 12, 2013

Filed:

Dec 18, 2009

Appl. No.:

12/653865

Inventors:

Peter Boderke - Schwalbach, DE
Alexander Gebauer - Wiesbaden, DE
Bhushan Hardas - Summerfield NC, US
Bernhard Hauptmeier - Gelnhausen, DE
Rainer Pooth - Bad Soden/Taunus, DE

Assignee:

Merz Pharma GmbH & Co. KGaA - Frankfurt am Main

International Classification:

A61K 31/13

US Classification:

514579

Abstract:

The present invention relates to the treatment of an individual afflicted with inflammatory skin diseases comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative.

US Patent:

20190282501, Sep 19, 2019

Filed:

Jan 25, 2017

Appl. No.:

16/072046

Inventors:

- Rehovot, IL
Julia Nomi Biso FEIMAN - Rehovot, IL
Dov TAMARKIN - Maccabim, IL
David SCHUZ - Gimzu, IL
Sarah Marissa CALEY - Chapel Hill NC, US
Bhushan HARDAS - Summerfield NC, US

Assignee:

FOAMIX PHARMACEUTICALS LTD. - Rehovot

International Classification:

A61K 9/12
A61P 31/10
A61K 31/135
A61K 47/10
A61K 47/38
A61K 47/18
A61K 9/00

Abstract:

The present disclosure relates to topical, hydroalcoholic foam formulations of antifungal agents, including allylamines such as naftifine. In some embodiments, the topical foam formulations comprise a carrier and a liquefied or compressed gas propellant, wherein the carrier comprises about 2% to about 4% by weight of naftifine hydrochloride; about 15% to about 35% by weight of a Calkyl alcohol; about 15% to about 30% by weight of an alkylene glycol; about 1% to about 2% by weight of a polymer; about 0.5% to about 2.0% by weight of a long chain fatty alcohol; a pH adjuster; about 0.01% to about 0.3% by weight of a chelating agent; water; and optionally about 0.5% to about 1.5% by weight of a preservative; wherein the propellant is present in the formation at about 5% to about 15% by weight of the formulation. Such compositions are useful for treating fungal infections including tinea capitis.

US Patent:

20140228440, Aug 14, 2014

Filed:

Mar 20, 2014

Appl. No.:

14/220567

Inventors:

- Frankfurt am Main, DE
Alexander Gebauer - Wiesbaden, DE
Bhushan Hardas - Summerfield NC, US
Bernhard Hauptmeier - Gelnhausen, DE
Rainer Pooth - Bad Soden/ Taunus, DE

Assignee:

MERZ PHARMA GmbH & CO. KGaA - Frankfurt am Main

International Classification:

A61K 31/13

US Classification:

514579

Abstract:

The present invention relates to the treatment of an individual afflicted with inflammatory skin diseases comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative.